MESFIN GEBREMICHAEL M.D.
Prescription History 1609957430
Internal Medicine - Pulmonary Disease in Lanham, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MESFIN GEBREMICHAEL M.D., an active Pulmonary Disease specialist practicing in Lanham, MD. Our medical registry currently tracks 32 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,708 documented patient claims. Among these therapy options, the most frequently utilized medication is Albuterol Sulfate Hfa, which accounts for 406 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 406 | $31.09 | ▲ More than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 406 Medicare prescriptions for Albuterol Sulfate Hfa, about 7.7 times the volume of the typical Maryland prescriber of this medication (52.6). Medicare paid an average of $31.09 per fill, versus $29.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 585.7 30-Day Fills standardized to 30-day supplies 16,191 Days of Medication total across all patients in 2024 | |||
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 363 | $858.19▼ below MD avg | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 363 Medicare prescriptions for Trelegy Ellipta, about 6.7 times the volume of the typical Maryland prescriber of this medication (54.2). Medicare paid an average of $858.19 per fill, versus $936.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 503 30-Day Fills standardized to 30-day supplies 15,073 Days of Medication total across all patients in 2024 | |||
| Methylprednisolone | 263 | $8.13 | ▲ More than typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2024, this provider wrote 263 Medicare prescriptions for Methylprednisolone, about 7.8 times the volume of the typical Maryland prescriber of this medication (33.6). Medicare paid an average of $8.13 per fill, versus $7.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 281.5 30-Day Fills standardized to 30-day supplies 2,536 Days of Medication total across all patients in 2024 | |||
| Breo ElliptaFluticasone/Vilanterol | 196 | $483.44▼ below MD avg | ▲ More than typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 196 Medicare prescriptions for Breo Ellipta, about 6.5 times the volume of the typical Maryland prescriber of this medication (30.4). Medicare paid an average of $483.44 per fill, versus $554.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 247 30-Day Fills standardized to 30-day supplies 7,410 Days of Medication total across all patients in 2024 | |||
| Fluticasone Propionate | 195 | $19.58 | ▲ More than typical |
About Fluticasone Propionate: Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. Show more ▾ It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 195 Medicare prescriptions for Fluticasone Propionate, about 4.6 times the volume of the typical Maryland prescriber of this medication (42.4). Medicare paid an average of $19.58 per fill, versus $16.42 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 408.8 30-Day Fills standardized to 30-day supplies 12,238 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 147 | $13.47▼ below MD avg | ▲ More than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 147 Medicare prescriptions for Montelukast Sodium, about 3.3 times the volume of the typical Maryland prescriber of this medication (44.3). Medicare paid an average of $13.47 per fill, versus $15.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 389.1 30-Day Fills standardized to 30-day supplies 11,672 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 129 | $5.01▼ below MD avg | ▲ More than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 129 Medicare prescriptions for Azithromycin, about 4 times the volume of the typical Maryland prescriber of this medication (32.1). Medicare paid an average of $5.01 per fill, versus $6.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 129 30-Day Fills standardized to 30-day supplies 908 Days of Medication total across all patients in 2024 | |||
| Spiriva RespimatTiotropium Bromide | 93 | $866.95 | ▲ More than typical |
About Spiriva Respimat: Tiotropium is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 93 Medicare prescriptions for Spiriva Respimat, about 2.9 times the volume of the typical Maryland prescriber of this medication (32.3). Medicare paid an average of $866.95 per fill, versus $659.59 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 159 30-Day Fills standardized to 30-day supplies 4,770 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 83 | $8.92▼ below MD avg | ▲ More than typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 83 Medicare prescriptions for Doxycycline Hyclate, about 2.8 times the volume of the typical Maryland prescriber of this medication (30.1). Medicare paid an average of $8.92 per fill, versus $13.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 87 30-Day Fills standardized to 30-day supplies 825 Days of Medication total across all patients in 2024 | |||
| Wixela InhubFluticasone Propion/Salmeterol | 71 | $92.66▼ below MD avg | ▲ More than typical |
About Wixela Inhub: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 71 Medicare prescriptions for Wixela Inhub, about 2.3 times the volume of the typical Maryland prescriber of this medication (31.2). Medicare paid an average of $92.66 per fill, versus $153.71 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 97 30-Day Fills standardized to 30-day supplies 2,910 Days of Medication total across all patients in 2024 | |||
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 69 | $683.46 | ▲ More than typical |
About Anoro Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: umeclidinium and vilanterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Vilanterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Umeclidinium/vilanterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as vilanterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 69 Medicare prescriptions for Anoro Ellipta, about 2.2 times the volume of the typical Maryland prescriber of this medication (31.3). Medicare paid an average of $683.46 per fill, versus $628.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 109 30-Day Fills standardized to 30-day supplies 3,270 Days of Medication total across all patients in 2024 | |||
| Incruse ElliptaUmeclidinium Bromide | 68 | $430.70▼ below MD avg | ▲ More than typical |
About Incruse Ellipta: Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. Muscarinic Antagonist. In 2024, this provider wrote 68 Medicare prescriptions for Incruse Ellipta, about 2.8 times the volume of the typical Maryland prescriber of this medication (24.3). Medicare paid an average of $430.70 per fill, versus $436.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 88 30-Day Fills standardized to 30-day supplies 2,640 Days of Medication total across all patients in 2024 | |||
| SymbicortBudesonide/Formoterol Fumarate | 61 | $380.21 | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 61 Medicare prescriptions for Symbicort, about 2.8 times the volume of the typical Maryland prescriber of this medication (21.9). Medicare paid an average of $380.21 per fill, versus $327.53 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 107 30-Day Fills standardized to 30-day supplies 3,210 Days of Medication total across all patients in 2024 | |||
| Prednisone | 59 | $11.82 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2024, this provider wrote 59 Medicare prescriptions for Prednisone, about 1.5 times the volume of the typical Maryland prescriber of this medication (40.4). Medicare paid an average of $11.82 per fill, versus $4.84 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 121.5 30-Day Fills standardized to 30-day supplies 3,645 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 59 | $116.16▼ below MD avg | ▲ More than typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 59 Medicare prescriptions for Fluticasone-Salmeterol, about 2.5 times the volume of the typical Maryland prescriber of this medication (23.7). Medicare paid an average of $116.16 per fill, versus $148.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 73 30-Day Fills standardized to 30-day supplies 2,190 Days of Medication total across all patients in 2024 | |||
| Arnuity ElliptaFluticasone Furoate | 50 | $236.81▼ below MD avg | ▲ More than typical |
About Arnuity Ellipta: Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Show more ▾ Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling (inflammation) of the airways in the lungs to make breathing easier. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 50 Medicare prescriptions for Arnuity Ellipta, about 2.1 times the volume of the typical Maryland prescriber of this medication (23.8). Medicare paid an average of $236.81 per fill, versus $315.15 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 66 30-Day Fills standardized to 30-day supplies 1,980 Days of Medication total across all patients in 2024 | |||
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $7.90▼ below MD avg | ▲ More than typical |
About Amoxicillin-Clavulanate Potass: Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2024, this provider wrote 43 Medicare prescriptions for Amoxicillin-Clavulanate Potass, about 1.7 times the volume of the typical Maryland prescriber of this medication (25.6). Medicare paid an average of $7.90 per fill, versus $10.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 43 30-Day Fills standardized to 30-day supplies 331 Days of Medication total across all patients in 2024 | |||
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $838.58▼ below MD avg | ≈ Typical |
About Breztri Aerosphere: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you maintain your normal activities and decreases time lost from work or school. This inhaler contains 3 medications: budesonide, glycopyrrolate, and formoterol. Budesonide works by reducing the irritation and swelling of the airways. Budesonide belongs to a class of drugs known as corticosteroids. Glycopyrrolate and formoterol work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Glycopyrrolate belongs to a class of drugs known as anticholinergics. Formoterol belongs to the class of drugs known as long-acting beta agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This medication is not approved to treat asthma. In 2024, this provider wrote 41 Medicare prescriptions for Breztri Aerosphere, about the same volume as the typical Maryland prescriber of this medication (38.4). Medicare paid an average of $838.58 per fill, versus $856.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 59 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Ipratropium Bromide | 39 | $32.36▼ below MD avg | ≈ Typical |
About Ipratropium Bromide: Ipratropium is used to treat a runny nose caused by the common cold or seasonal allergies. Show more ▾ It works by reducing the amount of fluid/mucus released from inside your nose. This medication does not relieve symptoms of stuffy nose or sneezing. A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. In 2024, this provider wrote 39 Medicare prescriptions for Ipratropium Bromide, about the same volume as the typical Maryland prescriber of this medication (34.8). Medicare paid an average of $32.36 per fill, versus $33.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 67 30-Day Fills standardized to 30-day supplies 1,770 Days of Medication total across all patients in 2024 | |||
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 37 | $749.92 | ≈ Typical |
About Stiolto Respimat: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 2 medications: tiotropium and olodaterol. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Olodaterol belongs to the class of drugs known as long-acting inhaled beta-agonists (LABAs). Both drugs are also known as bronchodilators. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. Tiotropium/olodaterol is not approved to treat asthma. People with asthma using long-acting inhaled beta agonists (such as olodaterol) without also using an inhaled corticosteroid may have an increased risk of serious (sometimes fatal) breathing problems. In 2024, this provider wrote 37 Medicare prescriptions for Stiolto Respimat, about 1.2 times the volume of the typical Maryland prescriber of this medication (30.7). Medicare paid an average of $749.92 per fill, versus $682.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 63 30-Day Fills standardized to 30-day supplies 1,890 Days of Medication total across all patients in 2024 | |||
| Azelastine Hcl | 32 | $36.56 | ≈ Typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia. In 2024, this provider wrote 32 Medicare prescriptions for Azelastine Hcl, about the same volume as the typical Maryland prescriber of this medication (33.3). Medicare paid an average of $36.56 per fill, versus $31.50 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 53.7 30-Day Fills standardized to 30-day supplies 1,510 Days of Medication total across all patients in 2024 | |||
| DuleraMometasone/Formoterol | 30 | $408.19▼ below MD avg | ▲ More than typical |
About Dulera: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ It contains 2 medications: mometasone and formoterol. Mometasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of mometasone furoate and formoterol fumarate that is used as an inhaled dosage form for the treatment of ASTHMA. In 2024, this provider wrote 30 Medicare prescriptions for Dulera, about 1.7 times the volume of the typical Maryland prescriber of this medication (17.4). Medicare paid an average of $408.19 per fill, versus $441.32 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 42.5 30-Day Fills standardized to 30-day supplies 1,228 Days of Medication total across all patients in 2024 | |||
| Ventolin HfaAlbuterol Sulfate | 30 | $55.30▼ below MD avg | ≈ Typical |
About Ventolin Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 30 Medicare prescriptions for Ventolin Hfa, about 1.2 times the volume of the typical Maryland prescriber of this medication (24.7). Medicare paid an average of $55.30 per fill, versus $70.04 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 32 30-Day Fills standardized to 30-day supplies 837 Days of Medication total across all patients in 2024 | |||
| Roflumilast | 25 | $113.78 | ≈ Typical |
About Roflumilast: Roflumilast is used to control and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis). Show more ▾ It should be used along with other medications (bronchodilators such as salmeterol, ipratropium) to treat COPD. It works by reducing the irritation and swelling of the airways. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath or wheezing. If sudden breathing problems occur, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 25 Medicare prescriptions for Roflumilast, about the same volume as the typical Maryland prescriber of this medication (24.2). Medicare paid an average of $113.78 per fill, versus $99.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2024 | |||
| Varenicline Tartrate | 24 | $226.41 | ▲ More than typical |
About Varenicline Tartrate: Varenicline is used by adults to help stop smoking. Show more ▾ To increase your chance of success, use this medication with a stop-smoking program that includes education, support, and counseling. Quitting smoking lowers your risk of heart and lung disease, as well as cancer. Varenicline works by blocking nicotine's effects in the brain that make you want to smoke. Discuss the risks and benefits of this medication, as well as other ways to quit smoking (such as nicotine replacement treatment), with your doctor. A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION. In 2024, this provider wrote 24 Medicare prescriptions for Varenicline Tartrate, about 1.3 times the volume of the typical Maryland prescriber of this medication (18). Medicare paid an average of $226.41 per fill, versus $223.77 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 856 Days of Medication total across all patients in 2024 | |||
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $890.81 | ≈ Typical |
About Combivent Respimat: This product is used to treat and prevent symptoms (wheezing and shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). Show more ▾ This product contains 2 medications: ipratropium and albuterol (also known as salbutamol). Both drugs work by relaxing the muscles around the airways so that the airways open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A combined pharmaceutical preparation of Ipratropium Bromide and Albuterol Sulfate that is used to treat the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 17 Medicare prescriptions for Combivent Respimat, about the same volume as the typical Maryland prescriber of this medication (18.7). Medicare paid an average of $890.81 per fill, versus $603.88 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2024 | |||
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $149.81▼ below MD avg | ≈ Typical |
About Budesonide-Formoterol Fumarate: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. In 2024, this provider wrote 16 Medicare prescriptions for Budesonide-Formoterol Fumarate, about 82% of the volume of the typical Maryland prescriber of this medication (19.5). Medicare paid an average of $149.81 per fill, versus $205.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2024 | |||
| Qvar RedihalerBeclomethasone Dipropionate | 14 | $364.07 | ≈ Typical |
About Qvar Redihaler: Beclomethasone is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. Show more ▾ This medication belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. This medication must be used regularly to prevent breathing problems (attacks of wheezing/shortness of breath). It does not work right away and should not be used to relieve an asthma attack. If an attack occurs, use your quick-relief inhaler as prescribed. An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA. In 2024, this provider wrote 14 Medicare prescriptions for Qvar Redihaler, about 89% of the volume of the typical Maryland prescriber of this medication (15.7). Medicare paid an average of $364.07 per fill, versus $348.65 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 14 | $510.81▼ below MD avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 14 Medicare prescriptions for Eliquis, about 18% of the volume of the typical Maryland prescriber of this medication (76.7). Medicare paid an average of $510.81 per fill, versus $934.44 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 14 30-Day Fills standardized to 30-day supplies 405 Days of Medication total across all patients in 2024 | |||
| Theophylline ErTheophylline Anhydrous | 12 | $110.62 | ▼ Less than typical |
About Theophylline Er: Theophylline is used to treat lung diseases such as asthma and COPD (bronchitis, emphysema). Show more ▾ It must be used regularly to prevent wheezing and shortness of breath. This medication belongs to a class of drugs known as xanthines. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. It also decreases the lungs' response to irritants. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. In 2024, this provider wrote 12 Medicare prescriptions for Theophylline Er, about half the volume of the typical Maryland prescriber of this medication (23.2). Medicare paid an average of $110.62 per fill, versus $66.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Doxycycline Monohydrate | 11 | $12.40▼ below MD avg | ▼ Less than typical |
About Doxycycline Monohydrate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 11 Medicare prescriptions for Doxycycline Monohydrate, about half the volume of the typical Maryland prescriber of this medication (25.4). Medicare paid an average of $12.40 per fill, versus $16.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 11 30-Day Fills standardized to 30-day supplies 77 Days of Medication total across all patients in 2024 | |||
| Fluticasone-VilanterolFluticasone/Vilanterol | 11 | $295.72▼ below MD avg | ▼ Less than typical |
About Fluticasone-Vilanterol: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2024, this provider wrote 11 Medicare prescriptions for Fluticasone-Vilanterol, about 65% of the volume of the typical Maryland prescriber of this medication (16.9). Medicare paid an average of $295.72 per fill, versus $335.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MESFIN GEBREMICHAEL M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Lanham, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
